Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Vilastobart in Germline BRCA-mutated Pancreatic Adenocarcinoma: NCT07765836 Clinical Landscape Report 2026
9 min read
Vilastobart in Germline BRCA-mutated Pancreatic Adenocarcinoma: NCT07765836 Clinical Landscape Report 2026
16 September 2026
NCT07765836 clinical landscape for Germline BRCA-mutated Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
Acetaminophen/Ibuprofen in Stomach Cancer: NCT07768514 Clinical Landscape Report 2026
9 min read
Acetaminophen/Ibuprofen in Stomach Cancer: NCT07768514 Clinical Landscape Report 2026
16 September 2026
NCT07768514 clinical landscape for Stomach Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nalfurafine Hydrochloride in Kidney Failure, Chronic: NCT07769073 Clinical Landscape Report 2026
9 min read
Nalfurafine Hydrochloride in Kidney Failure, Chronic: NCT07769073 Clinical Landscape Report 2026
16 September 2026
NCT07769073 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
[18F]Fluorbetazine in Alzheimer Disease: NCT07764679 Clinical Landscape Report 2026
9 min read
[18F]Fluorbetazine in Alzheimer Disease: NCT07764679 Clinical Landscape Report 2026
16 September 2026
NCT07764679 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
E2511 in Alzheimer Disease: NCT07768592 Clinical Landscape Report 2026
9 min read
E2511 in Alzheimer Disease: NCT07768592 Clinical Landscape Report 2026
16 September 2026
NCT07768592 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Apatinib Mesylate in Advanced gastric carcinoma: NCT07770113 Clinical Landscape Report 2026
9 min read
Apatinib Mesylate in Advanced gastric carcinoma: NCT07770113 Clinical Landscape Report 2026
16 September 2026
NCT07770113 clinical landscape for Advanced gastric carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mesalamine in Chronic diarrhea: NCT07767370 Clinical Landscape Report 2026
9 min read
Mesalamine in Chronic diarrhea: NCT07767370 Clinical Landscape Report 2026
16 September 2026
NCT07767370 clinical landscape for Chronic diarrhea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07777211 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07777211 Clinical Landscape Report 2026
16 September 2026
NCT07777211 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
TRB-001 (Tridem Bioscience) in Parkinson Disease: NCT07777484 Clinical Landscape Report 2026
9 min read
TRB-001 (Tridem Bioscience) in Parkinson Disease: NCT07777484 Clinical Landscape Report 2026
16 September 2026
NCT07777484 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mesalamine in Pouchitis: NCT07773948 Clinical Landscape Report 2026
9 min read
Mesalamine in Pouchitis: NCT07773948 Clinical Landscape Report 2026
16 September 2026
NCT07773948 clinical landscape for Pouchitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Finerenone in Diabetes Mellitus, Type 2: NCT07775846 Clinical Landscape Report 2026
9 min read
Finerenone in Diabetes Mellitus, Type 2: NCT07775846 Clinical Landscape Report 2026
16 September 2026
NCT07775846 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Alpelisib in Diabetes Mellitus, Type 2: NCT07778524 Clinical Landscape Report 2026
9 min read
Alpelisib in Diabetes Mellitus, Type 2: NCT07778524 Clinical Landscape Report 2026
16 September 2026
NCT07778524 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →